Literature DB >> 6238619

Comparison of structures of various human fibrinogens and a derivative thereof by a study of the kinetics of release of fibrinopeptides.

L S Hanna, H A Scheraga, C W Francis, V J Marder.   

Abstract

The kinetics of the thrombin-induced release of fibrinopeptides from several variants of human fibrinogen, and from the plasmin digestion fragment E thereof, have been studied by using an HPLC technique to separate the reaction products. The data were analyzed in terms of a Michaelis-Menten mechanism in which the A alpha and B beta chains compete for thrombin. Phosphorylation of Ser-3 of the A alpha chain appears to increase the rate of release of the corresponding phosphorylated peptide A from fibrinogen, due to enhanced binding of thrombin (lower value of the Michaelis-Menten constant KM). However, phosphorylation does not affect the rate of release of the unphosphorylated A or B peptides. Increase in the length of the gamma chain (at the C-terminus) does not affect the rate of release of any of the fibrinopeptides. The rate of release of the A peptide from fragment E (which is devoid of the B peptide) is similar to that for the complete fibrinogen molecule. These results are in agreement with an earlier conclusion [Martinelli, R. A., & Scheraga, H. A. (1980) Biochemistry 19, 2343] that the A alpha and B beta chains behave independently in their competition for thrombin; i.e., the hydrolyzable Arg-Gly bonds of the A alpha and B beta chains are both accessible to thrombin.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6238619     DOI: 10.1021/bi00315a025

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  9 in total

1.  Generation of forms of fragment E with differing thrombin-binding properties during digestion of fibrinogen by plasmin.

Authors:  C A Goodwin; V V Kakkar; M F Scully
Journal:  Biochem J       Date:  1992-02-01       Impact factor: 3.857

2.  Structural basis for sequential cleavage of fibrinopeptides upon fibrin assembly.

Authors:  Igor Pechik; Sergiy Yakovlev; Michael W Mosesson; Gary L Gilliland; Leonid Medved
Journal:  Biochemistry       Date:  2006-03-21       Impact factor: 3.162

3.  Mediation of fibrin-induced release of von Willebrand factor from cultured endothelial cells by the fibrin beta chain.

Authors:  J A Ribes; F Ni; D D Wagner; C W Francis
Journal:  J Clin Invest       Date:  1989-08       Impact factor: 14.808

4.  The structures and proteolytic specificities of autolysed human thrombin.

Authors:  J Y Chang
Journal:  Biochem J       Date:  1986-12-15       Impact factor: 3.857

5.  Effects of introducing fibrinogen Aalpha character into the factor XIII activation peptide segment.

Authors:  Madhavi A Jadhav; Giulia Isetti; Toni A Trumbo; Muriel C Maurer
Journal:  Biochemistry       Date:  2010-04-06       Impact factor: 3.162

6.  Cleavage of blood coagulation factor XIII and fibrinogen by thrombin during in vitro clotting.

Authors:  C S Greenberg; C C Miraglia; F R Rickles; M A Shuman
Journal:  J Clin Invest       Date:  1985-05       Impact factor: 14.808

7.  Effects of Post-Translational Modifications of Fibrinogen on Clot Formation, Clot Structure, and Fibrinolysis: A Systematic Review.

Authors:  Judith J de Vries; Charlotte J M Snoek; Dingeman C Rijken; Moniek P M de Maat
Journal:  Arterioscler Thromb Vasc Biol       Date:  2020-01-09       Impact factor: 8.311

8.  Case Report: Unmasked Inherited Dysfibrinogenemia After Everolimus Therapy.

Authors:  Alona A Merkulova; Steven C Mitchell; Sergei Merkulov; Alisa S Wolberg; Marguerite Neerman-Arbez; Alvin H Schmaier
Journal:  Front Med (Lausanne)       Date:  2020-11-27

Review 9.  The ABCs of the atypical Fam20 secretory pathway kinases.

Authors:  Carolyn A Worby; Joshua E Mayfield; Adam J Pollak; Jack E Dixon; Sourav Banerjee
Journal:  J Biol Chem       Date:  2021-01-08       Impact factor: 5.157

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.